Iman Fund
|
|||||||
Schedule of Investments
|
|||||||
February 28, 2017 (Unaudited)
|
|||||||
(Classifications are based on the North American Industry Classification System)
|
|||||||
Shares
|
Value
|
||||||
COMMON STOCKS - 97.1%
|
|||||||
Apparel Knitting Mills - 0.2%
|
|||||||
2,500
|
Columbia Sportswear Co.
|
$
|
137,350
|
||||
Architectural, Engineering, & Related Services - 0.5%
|
|||||||
30,400
|
Callon Petroleum Co. (a)
|
383,648
|
|||||
Audio & Video Equipment Manufacturing - 0.5%
|
|||||||
8,200
|
Dolby Laboratories, Inc. - Class A
|
400,898
|
|||||
Automotive Parts, Accessories & Tire Stores - 1.0%
|
|||||||
3,300
|
Advance Auto Parts, Inc.
|
516,813
|
|||||
810
|
O'Reilly Automotive, Inc. (a)
|
220,085
|
|||||
736,898
|
|||||||
Building Equipment Contractors - 0.5%
|
|||||||
6,500
|
EMCOR Group Inc.
|
399,620
|
|||||
Building Material & Supplies Dealers - 1.1%
|
|||||||
5,600
|
The Home Depot, Inc.
|
811,496
|
|||||
Chemical & Allied Products Merchant Wholesalers - 0.6%
|
|||||||
2,200
|
Acuity Brands, Inc.
|
464,860
|
|||||
Clothing Stores - 0.8%
|
|||||||
28,600
|
Express, Inc. (a)
|
321,464
|
|||||
4,600
|
Ross Stores, Inc.
|
315,468
|
|||||
636,932
|
|||||||
Commercial & Service Industry Machinery Manufacturing - 0.8%
|
|||||||
4,400
|
The Middleby Corp. (a)
|
610,324
|
|||||
Communications Equipment Manufacturing - 3.1%
|
|||||||
6,200
|
ADTRAN, Inc.
|
131,130
|
|||||
8,500
|
NETGEAR, Inc. (a)
|
465,800
|
|||||
24,000
|
QUALCOMM, Inc.
|
1,355,520
|
|||||
24,300
|
RADWARE Ltd. (a)(b)
|
375,435
|
|||||
2,327,885
|
|||||||
Computer & Peripheral Equipment Manufacturing - 2.5%
|
|||||||
13,900
|
Apple Inc.
|
1,904,161
|
|||||
Computer Systems Design & Related Services - 6.4%
|
|||||||
11,100
|
Accenture PLC - Class A (b)
|
1,359,750
|
|||||
13,100
|
Amdocs Ltd. (b)
|
794,515
|
|||||
7,535
|
Baidu, Inc. - ADR (a)(b)
|
1,312,070
|
|||||
3,500
|
F5 Networks, Inc. (a)
|
501,445
|
|||||
12,900
|
Synchronoss Technologies, Inc. (a)
|
349,332
|
|||||
6,500
|
VMware, Inc. - Class A (a)
|
584,285
|
|||||
4,901,397
|
|||||||
Cut & Sew Apparel Manufacturing - 1.8%
|
|||||||
11,700
|
lululemon athletica Inc. (a)
|
763,542
|
|||||
12,100
|
VF Corp.
|
634,645
|
|||||
1,398,187
|
Data Processing, Hosting & Related Services - 0.6%
|
|||||||
800
|
Automatic Data Processing, Inc.
|
82,096
|
|||||
1,860
|
CoStar Group Inc. (a)
|
377,915
|
|||||
460,011
|
|||||||
Drugs & Druggists' Sundries Merchant Wholesalers - 0.7%
|
|||||||
5,500
|
The Procter & Gamble Co.
|
500,885
|
|||||
Electrical Equipment Manufacturing - 2.2%
|
|||||||
59,000
|
ABB Ltd. - ADR (b)
|
1,330,450
|
|||||
20,400
|
Babcock & Wilcox Enterprises, Inc. (a)
|
336,600
|
|||||
1,667,050
|
|||||||
Electronic Shopping & Mail-Order Houses - 3.0%
|
|||||||
2,730
|
Amazon.com, Inc. (a)
|
2,306,959
|
|||||
Electronics & Appliance Stores - 0.6%
|
|||||||
9,900
|
Best Buy Co., Inc.
|
436,887
|
|||||
Engine, Turbine & Power Transmission Equipment Manufacturing - 2.1%
|
|||||||
14,100
|
Brunswick Corp.
|
844,449
|
|||||
5,000
|
Cummins, Inc.
|
742,450
|
|||||
1,586,899
|
|||||||
Fabric Mills - 0.4%
|
|||||||
9,236
|
Culp, Inc.
|
314,024
|
|||||
Footwear Manufacturing - 0.2%
|
|||||||
3,100
|
NIKE, Inc. - Class B
|
177,196
|
|||||
Freight Transportation Arrangement - 1.2%
|
|||||||
900
|
C.H. Robinson Worldwide, Inc.
|
72,333
|
|||||
15,200
|
Expeditors International of Washington, Inc.
|
856,976
|
|||||
929,309
|
|||||||
General Freight Trucking - 0.6%
|
|||||||
4,600
|
Old Dominion Freight Line, Inc. (a)
|
422,096
|
|||||
Grocery & Related Product Merchant Wholesalers - 1.5%
|
|||||||
24,100
|
Unilever PLC - ADR (b)
|
1,144,268
|
|||||
Home Furnishings Stores - 0.5%
|
|||||||
32,200
|
Kirkland's, Inc. (a)
|
363,860
|
|||||
Household Appliance Manufacturing - 0.6%
|
|||||||
7,900
|
iRobot Corp. (a)
|
450,932
|
|||||
Lawn & Garden Equipment & Supplies Stores - 0.5%
|
|||||||
4,000
|
MSC Industrial Direct Co., Inc. - Class A
|
402,360
|
|||||
Local Messengers & Local Delivery - 0.6%
|
|||||||
4,500
|
United Parcel Service, Inc. (UPS) - Class B
|
475,920
|
|||||
Machinery, Equipment & Supplies Merchant Wholesalers - 0.7%
|
|||||||
9,100
|
Hexcel Corp.
|
500,318
|
|||||
230
|
W.W. Grainger, Inc.
|
57,031
|
|||||
557,349
|
|||||||
Management, Scientific & Technical Consulting Services - 1.2%
|
|||||||
12,400
|
Korn/Ferry International
|
383,284
|
|||||
6,700
|
salesforce.com, Inc. (a)
|
545,045
|
|||||
928,329
|
Medical Equipment & Supplies Manufacturing - 5.7%
|
|||||||
9,700
|
Baxter International Inc.
|
493,924
|
|||||
4,210
|
C.R. Bard, Inc.
|
1,032,460
|
|||||
5,000
|
Dentsply Sirona Inc.
|
317,600
|
|||||
5,800
|
Edwards Lifesciences, Corp. (a)
|
545,432
|
|||||
640
|
Intuitive Surgical, Inc. (a)
|
471,680
|
|||||
4,900
|
Nevro Corp. (a)
|
470,351
|
|||||
800
|
Stryker Corp.
|
102,848
|
|||||
4,700
|
Teleflex Inc.
|
898,546
|
|||||
4,332,841
|
|||||||
Metal Ore Mining - 0.5%
|
|||||||
6,100
|
Franco-Nevada Corp. (b)
|
394,121
|
|||||
Miscellaneous Durable Goods Merchant Wholesalers - 1.4%
|
|||||||
4,520
|
3M Co.
|
842,302
|
|||||
2,000
|
Honeywell International, Inc.
|
249,000
|
|||||
1,091,302
|
|||||||
Motor Vehicle Body & Trailer Manufacturing - 1.1%
|
|||||||
40,900
|
Gentex Corp.
|
860,127
|
|||||
Motor Vehicle Manufacturing - 0.7%
|
|||||||
1,990
|
Tesla Motors, Inc. (a)
|
497,480
|
|||||
Motor Vehicle Parts Manufacturing - 0.3%
|
|||||||
1,900
|
WABCO Holdings Inc. (a)
|
213,332
|
|||||
Navigational, Measuring, Electromedical & Control Instruments Manufacturing - 1.9%
|
|||||||
4,500
|
Agilent Technologies, Inc.
|
230,850
|
|||||
5,800
|
Coherent, Inc. (a)
|
1,058,964
|
|||||
6,000
|
NxStage Medical, Inc. (a)
|
171,360
|
|||||
1,461,174
|
|||||||
Newspaper, Periodical, Book & Directory Publishers - 2.1%
|
|||||||
84,486
|
RELX PLC - ADR (b)
|
1,606,079
|
|||||
Nonmetallic Mineral Mining & Quarrying - 0.4%
|
|||||||
1,500
|
Martin Marietta Materials, Inc.
|
323,925
|
|||||
Office Furniture (Including Fixtures) Manufacturing - 0.8%
|
|||||||
21,300
|
La-Z-Boy Incorporated
|
575,100
|
|||||
Oil & Gas Extraction - 1.1%
|
|||||||
3,700
|
Diamondback Energy Inc (a)
|
373,182
|
|||||
1,300
|
EOG Resources, Inc.
|
126,087
|
|||||
4,700
|
Occidental Petroleum Corp.
|
308,085
|
|||||
807,354
|
|||||||
Other General Merchandise Stores - 0.5%
|
|||||||
5,100
|
Dollar General Corporation
|
372,402
|
|||||
Other General Purpose Machinery Manufacturing - 0.7%
|
|||||||
3,050
|
Snap-on Incorporated
|
517,493
|
|||||
Other Information Services - 5.3%
|
|||||||
2,015
|
Alphabet Inc. - Class A (a)
|
1,702,534
|
|||||
1,320
|
Alphabet Inc. - Class C (a)
|
1,086,638
|
|||||
9,500
|
Facebook Inc. - Class A (a)
|
1,287,630
|
|||||
4,076,802
|
Other Leather & Allied Product Manufacturing - 0.2%
|
|||||||
3,800
|
Coach, Inc.
|
144,742
|
|||||
Paint, Coating & Adhesive Manufacturing - 0.1%
|
|||||||
800
|
PPG Industries, Inc.
|
81,944
|
|||||
Petroleum & Coal Products Manufacturing - 3.0%
|
|||||||
20,500
|
Exxon Mobil Corp.
|
1,667,060
|
|||||
9,500
|
Valero Energy Corp.
|
645,525
|
|||||
2,312,585
|
|||||||
Pharmaceutical & Medicine Manufacturing - 14.0%
|
|||||||
12,000
|
Alkermes PLC (a)(b)
|
678,000
|
|||||
5,350
|
Allergan plc (b)
|
1,309,787
|
|||||
8,100
|
Alnylam Pharmaceuticals, Inc. (a)
|
418,284
|
|||||
628
|
Bioverativ Inc. (a)
|
32,680
|
|||||
3,200
|
Bristol-Myers Squibb Co.
|
181,472
|
|||||
2,400
|
IDEXX Laboratories, Inc. (a)
|
347,856
|
|||||
4,400
|
Ionis Pharmaceuticals, Inc. (a)
|
218,988
|
|||||
14,400
|
Johnson & Johnson
|
1,759,824
|
|||||
18,400
|
Merck & Co., Inc.
|
1,212,008
|
|||||
58,700
|
Nektar Therapeutics (a)
|
767,796
|
|||||
38,400
|
Novartis AG - ADR (b)
|
3,001,728
|
|||||
300
|
Regeneron Pharmaceuticals, Inc. (a)
|
112,050
|
|||||
6,800
|
Seattle Genetics, Inc. (a)
|
446,420
|
|||||
2,300
|
Vertex Pharmaceuticals Inc. (a)
|
208,426
|
|||||
10,695,319
|
|||||||
Professional & Commercial Equipment & Supplies Merchant Wholesalers - 0.9%
|
|||||||
4,000
|
Henry Schein, Inc. (a)
|
686,240
|
|||||
Rubber Product Manufacturing - 0.3%
|
|||||||
2,400
|
Carlisle Companies Incorporated
|
247,920
|
|||||
Scheduled Air Transportation - 0.8%
|
|||||||
9,900
|
Southwest Airlines Co.
|
572,220
|
|||||
Scientific Research & Development Services - 0.5%
|
|||||||
1,255
|
Biogen Idec Inc. (a)
|
362,193
|
|||||
Semiconductor & Other Electronic Component Manufacturing - 7.3%
|
|||||||
7,200
|
Amphenol Corp. - Class A
|
498,312
|
|||||
1,100
|
Analog Devices, Inc.
|
90,123
|
|||||
20,700
|
Applied Materials, Inc.
|
749,754
|
|||||
5,683
|
Cavium, Inc. (a)
|
372,293
|
|||||
24,600
|
Intel Corp.
|
890,520
|
|||||
19,800
|
Jabil Circuit, Inc.
|
505,098
|
|||||
13,200
|
NVIDIA Corp.
|
1,339,536
|
|||||
8,700
|
Texas Instruments Inc.
|
666,594
|
|||||
7,500
|
Xilinx, Inc.
|
441,150
|
|||||
5,553,380
|
|||||||
Services to Buildings & Dwellings - 0.7%
|
|||||||
14,100
|
Rollins, Inc.
|
515,496
|
|||||
Shoe Stores - 0.7%
|
|||||||
7,400
|
Foot Locker, Inc.
|
559,958
|
|||||
Soap, Cleaning Compound & Toilet Preparation Manufacturing - 0.6%
|
|||||||
9,900
|
Church & Dwight Co, Inc.
|
493,416
|
|||||
Software Publishers - 7.0%
|
|||||||
6,000
|
ANSYS, Inc. (a)
|
640,560
|
|||||
4,900
|
Citrix Systems, Inc. (a)
|
386,855
|
|||||
1,400
|
Intuit Inc.
|
175,616
|
|||||
500
|
MercadoLibre Inc.
|
105,435
|
|||||
20,800
|
Microsoft Corp.
|
1,330,784
|
|||||
8,400
|
PTC, Inc. (a)
|
452,676
|
|||||
7,200
|
Red Hat, Inc. (a)
|
596,232
|
|||||
6,900
|
Splunk Inc. (a)
|
425,937
|
|||||
10,600
|
Synopsys, Inc. (a)
|
757,264
|
|||||
2,900
|
Tyler Technologies, Inc. (a)
|
439,785
|
|||||
5,311,144
|
|||||||
Travel Arrangement & Reservation Services - 0.9%
|
|||||||
405
|
The Priceline Group, Inc. (a)
|
698,273
|
|||||
Wholesale Electronic Markets & Agents & Brokers - 0.6%
|
|||||||
4,500
|
Genuine Parts Co.
|
430,695
|
|||||
TOTAL COMMON STOCKS (Cost $63,067,338)
|
74,033,047
|
||||||
PREFERRED STOCK - 2.6%
|
|||||||
Wired Telecommunications Carriers - 2.6%
|
|||||||
139,800
|
Telefonica Brasil S.A. - ADR (b)
|
2,014,518
|
|||||
TOTAL PREFERRED STOCK (Cost $1,693,789)
|
2,014,518
|
||||||
Total Investments (Cost $64,761,127) - 99.7%
|
76,047,565
|
||||||
Other Assets in Excess of Liabilities - 0.3%
|
216,010
|
||||||
TOTAL NET ASSETS - 100.0%
|
$
|
76,263,575
|
Percentages are stated as a percent of net assets.
|
|||
ADR
|
American Depositary Receipt
|
||
(a)
|
Non Income Producing
|
||
(b)
|
Foreign Issued Securities
|
The cost basis of investments for federal income tax purposes at February 28, 2017 was as follows*:
|
|||||
Cost of investments
|
$
|
64,761,127
|
|||
Gross unrealized appreciation on investments
|
12,782,589
|
||||
Gross unrealized depreciation on investments
|
(1,496,151
|
)
|
|||
Net unrealized appreciation on investments
|
$
|
11,286,438
|
|||
*Because tax adjustments are calculated annually, the above table does not reflect tax adjustments. For the previous
|
|||||
fiscal year’s federal income tax information, please refer to the Notes to Financial Statements section in the Fund’s
|
|||||
most recent semi-annual or annual report.
|
Summary of Fair Value Exposure at February 28, 2017 (Unaudited)
|
|||||||
The Trust has performed an analysis of all existing investments to determine the significance and character of all inputs to their fair value determination. Various inputs are used in determining the value of the Fund’s investments. These inputs are summarized in the three broad levels listed below:
|
|||||||
Level 1 - Quoted prices in active markets for identical securities.
|
|
|
|
|
|
|
|
Level 2 - Other significant observable inputs (including quoted prices for similar securities in active markets, quoted prices for identical or similar instruments in markets that are not active, model-derived valuations in which all significant inputs and significant value drivers are observable in active markets, interest rates, prepayment speeds, credit risk, etc.)
|
|||||||
Level 3 - Significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)
|
|
|
|||||
Inputs that are used in determining a fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments, and is affected by various factors such as the type of investment or similar investments in the marketplace. The inputs will be considered by the Adviser, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the measurement date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy.
|
|||||||
Investments falling into the Level 3 category are primarily supported by quoted prices from brokers and dealers participating in the market for those investments. However, these may be classified as Level 3 investments due to lack of market transparency and corroboration to support these quoted prices. Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models rely on one or more significant unobservable inputs and/or significant assumptions by the Adviser. Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable company data.
|
|||||||
|
|
|
|
|
|
|
|
The inputs or methodology used for valuing securities are not an indication of the risk associated with investing in those securities.
|
|||||||
The following is a summary of the inputs used to value the Fund’s net assets as of February 28, 2017:
|
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
Common Stocks
|
$
|
74,033,047
|
-
|
-
|
$
|
74,033,047
|
||||||||||
Preferred Stock
|
2,014,518
|
-
|
-
|
2,014,518
|
||||||||||||
Total*
|
$
|
76,047,565
|
-
|
-
|
$
|
76,047,565
|
||||||||||
* Additional information regarding the industry and/or geographical classification of these investments is disclosed in the Schedule of Investments.
|
|||||||
There were no transfers into or out of Level 1, Level 2 or Level 3 fair value measurements during the reporting period for the Fund, as compared to their classification from the most recent annual report. It is the Fund’s policy to consider transfers into or out of Level 1, Level 2 or Level 3 as of the end of the reporting period.
|
|||||||
Derivatives and Hedging Activities at February 28, 2017 (Unaudited)
|
|||||||
|
|
|
|
|
|
|
|
The Trust has adopted an accounting standard involving disclosures of derivatives and hedging activities. The standard is intended to improve financial reporting
|
|||||||
for derivative instruments by requiring enhanced disclosure that enables investors to understand how and why an entity uses derivatives, how derivatives are
|
|||||||
accounted for and how derivative instruments affect an entity's results of operations and financial position. The standard does not have any impact on the Fund's
|
|||||||
financial disclosures because the Fund has not maintained any positions in derivative instruments or engaged in hedging activities.
|
|||||||
|
|||||||
In January, 2013, the FASB issued ASU No. 2013-01 “Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities” in GAAP and International Reporting Financial Standards (“IFRS”). ASU No. 2013-01 clarifies ASU No. 2011-11. Disclosures about Offsetting Assets and Liabilities to increase comparability and reduce presentation differences between financial statements prepared in accordance with GAAP and financial statements prepared in accordance with IFRS. This requires increased disclosure about derivative instruments that are offset in a reporting entity’s Statement of Assets and Liabilities and derivative instruments that are subject to a master netting agreement (“MNA”).
|
|||||||
Specifically, the ASU requires reporting entities to present separately for assets and liabilities. a) the gross amounts of those recognized assets and recognized liabilities, b) the amounts offset to determine the net amounts presented in the Statement of Assets and Liabilities, c) The net amount presented in the Statement of Assets and Liabilities, d) the amounts subject to an enforceable MNA not included in (b), and e) the net amount after deducting the amounts from (d) and (c). The effective date of the ASU is for interim and annual periods beginning on or after January 1, 2013. There is no impact of the ASU on the financial statements of the Fund for the three months ended February 28, 2017.
|
|||||||
|
|
|
|
|
|
|
|
In August 2014, the FASB issued ASU 2014-15 — Presentation of Financial Statements — Going Concern (Subtopic 205-40). The pronouncement determines management’s responsibility regarding assessment of the Funds’ ability to continue as a going concern, even if the Funds’ liquidation is not imminent. Currently, no similar guidance exists. Under this guidance, during each period in which financial statements are prepared, management needs to evaluate whether there are conditions or events that, in the aggregate, raise substantial doubt about the Funds’ ability to continue as a going concern within one year after the date the financial statements are issued. Substantial doubt exists if these conditions or events indicate that the Funds will be unable to meet their obligations as they become due. If such conditions or events exist, management should develop a plan to mitigate or alleviate these conditions or events. Regardless of management’s plan to mitigate, certain disclosures must be made in the financial statements. ASU 2014-15 is effective for annual periods ending after December 15, 2016, however, early adoption is permitted. Management does not believe that the update will have an impact on the Funds’ financial statements.
|
(a)
|
The Registrant’s President and Treasurer have concluded that the Registrant's disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940 (the “1940 Act”)) (17 CFR 270.30a-3(c)) are effective as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rule 13a-15(b) or Rule 15d‑15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(d)).
|
(b)
|
There were no changes in the Registrant's internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) (17 CFR 270.30a-3(d)) that occurred during the Registrant's last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting.
|
1.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
2.
|
Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
|
3.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation;
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
4.
|
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: April 26, 2017
|
/s/ Bassam Osman
|
Bassam Osman, President
|
1.
|
I have reviewed this report on Form N-Q of Allied Asset Advisors Funds;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
|
(a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
(b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
(c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation;
|
(d)
|
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
(a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
|
(b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date: May 1, 2017
|
/s/ Mohammad Basheeruddin
|
Mohammad Basheeruddin, Treasurer
|